Mesenchymal Stem Cells in Post-COVID Syndrome Experimental Treatment – Information
Post-COVID Syndrome and the stem cells therapy
What we have learned from the terribly hard lesson in the 2020, is that even the mild case of COVID-19 could cause very severe symptoms such as extreme fatigue or a brain fog. The situation is even more complicated with Patients who had a really advanced COVID infection. Although COVID-19 is seen as a disease that primarily affects the lungs, it can damage many other organs as well. We are still learning how to prevent this infection to spread and treat it. Now, the more patients have recovered, scientists and doctor’s report that the Covid-caused organ damage may increase the risk of long-term health problems.
What are the most common symptoms of post-COVID syndrome?
The most common symptoms that can linger include:
- General Fatigue
- Difficulty breathing
- Joint pain
- Chest pain
- Brain fog, including an inability to concentrate and impaired memory
- Loss of taste and/or smell
- Sleep issues
Unfortunately, in the severe course of the disease, some organs may be severely affected.
- LUNGS – Most recognized side-effect of Covid and the post-Covid complication. Pneumonia caused by the Sars_CoV_2 virus can cause long-standing damage to the tiny air sacs (alveoli) in the lungs. The scar tissue and lungs degeneration can lead to long-term breathing problems.
- HEART – Surprisingly, the heart scans made after the recovery from COVID-19 have shown lasting damage to the heart muscle, even in people who experienced only mild COVID-19 symptoms. The heart tissue damage can increase the risk of heart failure or other heart complications in the future and is partially responsible for tiredness and much weaker body efficiency.
- BRAIN – Even in young people, COVID-19 can cause strokes, seizures and Guillain-Barre syndrome — a condition that causes temporary paralysis. It is supposed that the virus may also increase the risk of developing Parkinson’s disease and Alzheimer’s disease.
Chronic post-SARS is characterized by persistent fatigue, diffuse myalgia, weakness, depression, and nonrestorative sleep with associated REM-related apneas/hypopneas, an elevated sleep EEG cyclical alternating pattern, and alpha EEG sleep anomaly.
What are Stem Cells and how they can help in post COVID syndrome treatment?
Stem Cells are unique biological cells that have the ability to become many different types of cells and can divide to produce more of the stem cells same type – they can replicate rapidly. They are vital in the body’s healing process. The discovery of stem cells in the umbilical cord has been a huge step in the stem cells reproductive medicine, as using the stem cells from the donor may not always be compatible, and using our own cells may be connected with duplication a genetic mistake. There is a huge potential in treating diseases previously recognized as untreatable, with stem cells.
Which kind of Stem Cells are applicable in the post COVID Therapy?
The special stem cells used in diabetes therapy are cells that come from the human umbilical cord, Wharton’s Jelly. These stem cells are called allogeneic mesenchymal – mesenchymal stem cells (MSCs). The umbilical cords are donated by moms after healthy births, and all are screened for bacterias and viruses due to the Stem Cells Bank Guidelines.
Mesenchymal Stem Cells from Wharton’s Jelly do not carry any risk of genetic disorders. These wonderful cells are able to differentiate into brain cells, neurons, and rebuild the brain areas, which do not function properly as a result of COVID.
How do stem cells help in post-COVID Syndrome?
Why are mesenchymal stem cells good for this treatment?
- MSCs from Wharton’s Jelly show reduced the incidence of GVHD- graft-versus-host disease
- MSCs from the umbilical cord are more tolerant of tissue mismatches
- Umbilical cord stem cells show a decreased risk of any transmissible viral infections
- Preserved cord stem cells have the ability to cross the blood-brain barrier
- Wharton’s jelly stem cells are able to differentiate into neurons and other brain cells and tissues
Please note, that this therapy is available as a medical experiment, and a qualification process depends on meeting the criteria as well as a positive opinion of a bioethical committee. All medical treatments have varied outcomes and vary from patient to patient. Your application will be considered by the team of doctor’s and consultants. For more information please e-mail us directly.